Bright Minds Biosciences (DRUG) Other Operating Expenses (2024 - 2026)

Bright Minds Biosciences has reported Other Operating Expenses for 3 years, with the latest figure at -$19.6 million in Q1 2026.

• For the quarter ending Q1 2026, Other Operating Expenses fell 5425.29% year-over-year to -$19.6 million; the trailing twelve-month figure through Mar 2026 stood at -$23.2 million (down 6913.25% YoY), and the FY2025 full-year result was $1.4 million, up 34.27% from the prior year.
• Other Operating Expenses for Q1 2026 stood at -$19.6 million, down from -$10.3 million in the prior quarter.
• The five-year high for Other Operating Expenses was $13.1 million in Q3 2025, with the low at -$19.6 million in Q1 2026.
• Historically, Other Operating Expenses has averaged -$2.5 million across 3 years, with a median of $230888.4 in 2024.
• Annual changes were most pronounced in 2025 — Other Operating Expenses jumped 5593.72% — and 2026, when it plunged 5425.29%.
• Bright Minds Biosciences' Other Operating Expenses stood at -$771430.5 in 2024, then plunged by 1238.16% to -$10.3 million in 2025, then slumped by 90.34% to -$19.6 million in 2026.
• The last three Other Operating Expenses figures came in at -$19.6 million (Q1 2026), -$10.3 million (Q4 2025), and $13.1 million (Q3 2025), per Business Quant data.